4//SEC Filing
Fjaellskog Marie-Louise 4
Accession 0001209191-21-008087
CIK 0001829802other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:39 PM ET
Size
5.8 KB
Accession
0001209191-21-008087
Insider Transaction Report
Form 4
Fjaellskog Marie-Louise
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-03+79,166→ 79,166 totalExercise: $19.00Exp: 2031-02-02→ Common Stock (79,166 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the options granted hereby shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, February 3, 2021, thereafter one forty-eighth (1/48th) of the options granted shall vest and become exercisable each month following the Vesting Commencement Date, over four years such that the options shall be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the grantee's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each such vesting date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001843544
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:39 PM ET
- Size
- 5.8 KB